Our recent CLL Global Research Foundation featured CLL Global President, Dr. William Wierda, and Dr. Erin Parry from Dana-Farber Cancer Institute. CLL patient advocate Jeff Folloder moderated the event.
The experts discussed CLL research news from the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA) meetings, the latest in Richter’s Transformation, and advances in CLL treatment approaches.
The panel also answered questions from the audience, covering a range of topics from treatment sequencing to the latest advice on COVID vaccination.
Read the transcript.
Download the slide presentation.
Expert Panel:
Dr. William Wierda, President & CEO, CLL Global Research Foundation
Dr. Erin Parry, Investigator, Hematologic Neoplasia at Dana-Farber Cancer Institute
Jeff Folloder, Moderator and CLL patient advocate
